• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在恶性疟原虫中,哌喹体外反应与 pfcrt、pfmdr1、pfmrp 和 pfnhe 基因多态性之间无关联。

Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.

机构信息

Unité de Recherche en Biologie et Epidémiologie Parasitaires, Institut de Recherche Biomédicale des Armées-Antenne de Marseille, Allée du Médecin-colonel Jamot, Parc le Pharo, BP 60109, 13262 Marseille Cedex 7, France.

出版信息

Antimicrob Agents Chemother. 2010 Sep;54(9):3537-44. doi: 10.1128/AAC.00183-10. Epub 2010 Jun 14.

DOI:10.1128/AAC.00183-10
PMID:20547801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2935001/
Abstract

We have analyzed the profiles of 23 of Plasmodium falciparum strains for their in vitro chemosusceptibilities to piperaquine (PPQ), dihydroartemisinin (DHA), chloroquine, monodesethylamodiaquine, quinine, mefloquine, lumefantrine, atovaquone, pyrimethamine, and doxycycline (DOX) in association with polymorphisms in genes involved in quinoline resistance (Plasmodium falciparum crt [pfcrt], pfmdr1, pfmrp, and pfnhe). The 50% inhibitory concentrations (IC(50)s) for PPQ ranged from 29 to 98 nM (geometric mean = 57.8 nM, 95% confidence interval [CI] = 51 to 65) and from 0.4 to 5.8 nM for DHA (geometric mean = 1.8 nM, 95% CI = 1.4 to 2.3). We found a significant positive correlation between the responses to PPQ and DHA (r(2) = 0.17; P = 0.0495) and between the responses to PPQ and DOX (r(2) = 0.41; P = 0.001). We did not find a significant association between the PPQ IC(50) (0.0525 < P < 0.9247) or the DHA IC(50) (0.0138 < P < 0.9018) and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe-1 genes. There was an absence of cross-resistance with quinolines, and the IC(50)s for PPQ and DHA were found to be unrelated to mutations in the pfcrt, pfmdr1, pfmrp, and pfnhe-1 transport protein genes, which are involved in quinoline antimalarial drug resistance. These results confirm the interest in and the efficacy of the combination of PPQ and DHA for areas in which parasites are resistant to chloroquine or other quinolines.

摘要

我们分析了 23 株恶性疟原虫株对哌喹(PPQ)、双氢青蒿素(DHA)、氯喹、去乙基阿莫地喹、奎宁、甲氟喹、青蒿琥酯、阿托伐醌、氨苯砜和强力霉素(DOX)的体外化学敏感性,并与涉及奎宁耐药的基因(恶性疟原虫 CRT [pfcrt]、pfmdr1、pfmrp 和 pfnhe)中的多态性相关联。PPQ 的 50%抑制浓度(IC(50))范围为 29 至 98 nM(几何平均值 = 57.8 nM,95%置信区间 [CI] = 51 至 65),DHA 的 IC(50)范围为 0.4 至 5.8 nM(几何平均值 = 1.8 nM,95%CI = 1.4 至 2.3)。我们发现 PPQ 和 DHA 的反应之间存在显著的正相关(r(2)= 0.17;P = 0.0495),以及 PPQ 和 DOX 的反应之间存在显著的正相关(r(2)= 0.41;P = 0.001)。我们没有发现 PPQ IC(50)(0.0525 < P < 0.9247)或 DHA IC(50)(0.0138 < P < 0.9018)与 pfcrt、pfmdr1、pfmrp 和 pfnhe-1 基因多态性之间存在显著关联。与喹啉类药物没有交叉耐药性,PPQ 和 DHA 的 IC(50)与 pfcrt、pfmdr1、pfmrp 和 pfnhe-1 转运蛋白基因的突变无关,这些基因与喹啉类抗疟药物耐药有关。这些结果证实了 PPQ 和 DHA 联合使用的有效性和前景,适用于对氯喹或其他喹啉类药物有耐药性的寄生虫的地区。

相似文献

1
Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.在恶性疟原虫中,哌喹体外反应与 pfcrt、pfmdr1、pfmrp 和 pfnhe 基因多态性之间无关联。
Antimicrob Agents Chemother. 2010 Sep;54(9):3537-44. doi: 10.1128/AAC.00183-10. Epub 2010 Jun 14.
2
Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum.吡喹酮在体外反应与恶性疟原虫喹啉类耐药相关基因多态性之间无相关性。
Malar J. 2010 Nov 25;9:339. doi: 10.1186/1475-2875-9-339.
3
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.在肯尼亚恶性疟原虫分离株中哌喹、青蒿琥酯和二氢青蒿素的体外活性以及 pfcrt 和 pfmdr1 的多态性。
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73. doi: 10.1128/AAC.00638-09. Epub 2009 Sep 21.
4
A Variant PfCRT Isoform Can Contribute to Resistance to the First-Line Partner Drug Piperaquine.一种变异的疟原虫氯喹抗性转运蛋白(PfCRT)异构体可能导致对一线联合用药磷酸哌喹产生耐药性。
mBio. 2017 May 9;8(3):e00303-17. doi: 10.1128/mBio.00303-17.
5
Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran.伊朗恶性疟原虫pfcrt、pfmdr1和pfmrp基因中与喹啉耐药相关的多态性
Acta Trop. 2006 Mar;97(3):352-6. doi: 10.1016/j.actatropica.2006.01.002. Epub 2006 Feb 20.
6
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.在布基纳法索,蒿甲醚-本芴醇和双氢青蒿素-哌喹对恶性疟原虫Pfcrt和Pfmdr1变体的体内选择
Antimicrob Agents Chemother. 2015 Jan;59(1):734-7. doi: 10.1128/AAC.03647-14. Epub 2014 Nov 17.
7
Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.恶性疟原虫 Na+/H+ 交换蛋白多态性与奎宁反应的差异关联:来自现场和培养适应的恶性疟原虫分离株的研究。
Antimicrob Agents Chemother. 2011 Dec;55(12):5834-41. doi: 10.1128/AAC.00477-11. Epub 2011 Sep 26.
8
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.磷酸咯萘啶的体外活性与恶性疟原虫中与喹啉抗性相关的转运蛋白基因多态性无关。
Antimicrob Agents Chemother. 2008 Aug;52(8):2755-9. doi: 10.1128/AAC.00060-08. Epub 2008 May 27.
9
Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.哌喹耐药柬埔寨疟原虫临床分离株的体外基因和表型特征。
Malar J. 2020 Jul 25;19(1):269. doi: 10.1186/s12936-020-03339-w.
10
In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.肯尼亚分离疟原虫株中奎宁和其他抗疟药物的体外活性与 pfnep 多态性。
Antimicrob Agents Chemother. 2010 Aug;54(8):3302-7. doi: 10.1128/AAC.00325-10. Epub 2010 Jun 1.

引用本文的文献

1
Design, Synthesis, and Development of 4-[(7-Chloroquinoline-4-yl)amino]phenol as a Potential SARS-CoV-2 Mpro Inhibitor.4-[(7-氯喹啉-4-基)氨基]苯酚作为潜在的严重急性呼吸综合征冠状病毒2主蛋白酶抑制剂的设计、合成与开发
ChemistrySelect. 2022 Apr 21;7(15):e202200125. doi: 10.1002/slct.202200125. Epub 2022 Apr 19.
2
Multidrug Resistance Proteins (MRPs).多药耐药蛋白(MRPs)。
Front Pharmacol. 2021 Nov 1;12:759422. doi: 10.3389/fphar.2021.759422. eCollection 2021.
3
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.氯喹和羟氯喹在疟疾治疗中的应用和在 COVID-19 治疗中的再利用。
Pharmacol Ther. 2020 Dec;216:107672. doi: 10.1016/j.pharmthera.2020.107672. Epub 2020 Sep 8.
4
Unsymmetrical Bisquinolines with High Potency against Malaria.具有高效抗疟活性的不对称双喹啉
Molecules. 2020 May 10;25(9):2251. doi: 10.3390/molecules25092251.
5
Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?在东南亚,k13 和疟原虫裂殖子表面蛋白 2(plasmepsin II)基因与对青蒿素衍生物和哌喹的耐药性有关,那么这些基因是否可用于监测非洲的耐药性?
Malar J. 2019 Aug 23;18(1):285. doi: 10.1186/s12936-019-2916-6.
6
Baseline and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal.塞内加尔实施双氢青蒿素-哌喹之前恶性疟原虫分离株的基线和分子反应对哌喹的反应
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02445-18. Print 2019 May.
7
Influence of the Gene on In Vitro Sensitivities of Piperaquine in Thai Isolates of .该基因对泰国分离株中哌喹体外敏感性的影响。
Am J Trop Med Hyg. 2017 Mar;96(3):624-629. doi: 10.4269/ajtmh.16-0668. Epub 2017 Apr 6.
8
Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.超重患者因用药剂量不足导致双氢青蒿素加磷酸哌喹治疗恶性疟失败。
Malar J. 2016 Sep 20;15:479. doi: 10.1186/s12936-016-1535-8.
9
The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.氧化还原循环剂疟原酮是一种速效抗疟先导化合物,对有性和早期无性血液阶段寄生虫具有显著活性。
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5146-58. doi: 10.1128/AAC.02975-15. Print 2016 Sep.
10
The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine.恶性疟原虫氯喹抗性转运蛋白与恶性疟原虫非洲株对咯萘啶的体外反应相关。
Parasit Vectors. 2016 Feb 9;9:77. doi: 10.1186/s13071-016-1358-z.

本文引用的文献

1
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.双氢青蒿素-哌喹与青蒿琥酯-咯萘啶治疗非洲儿童无并发症疟疾:一项随机、非劣效性试验。
PLoS One. 2009 Nov 17;4(11):e7871. doi: 10.1371/journal.pone.0007871.
2
Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers.疟原虫分离株对强力霉素的敏感性与 pftetQ 序列多态性以及 pftetQ 和 pfmdt 拷贝数有关。
J Infect Dis. 2010 Jan 1;201(1):153-9. doi: 10.1086/648594.
3
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.乌干达含阿莫地喹抗疟方案对药物敏感性降低的寄生虫的选择。
J Infect Dis. 2009 Dec 1;200(11):1650-7. doi: 10.1086/647988.
4
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.青蒿素类复方疗法:消除疟疾工作的重要工具。
Nat Rev Microbiol. 2009 Dec;7(12):864-74. doi: 10.1038/nrmicro2239. Epub 2009 Nov 2.
5
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.蒿甲醚-本芴醇与双氢青蒿素-哌喹治疗恶性疟原虫疟疾:乌干达儿童的一项纵向随机试验。
Clin Infect Dis. 2009 Dec 1;49(11):1629-37. doi: 10.1086/647946.
6
Chloroquine transport via the malaria parasite's chloroquine resistance transporter.氯喹通过疟原虫的氯喹抗性转运蛋白进行转运。
Science. 2009 Sep 25;325(5948):1680-2. doi: 10.1126/science.1175667.
7
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.在肯尼亚恶性疟原虫分离株中哌喹、青蒿琥酯和二氢青蒿素的体外活性以及 pfcrt 和 pfmdr1 的多态性。
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73. doi: 10.1128/AAC.00638-09. Epub 2009 Sep 21.
8
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.氯喹-氨苯砜-青蒿琥酯与蒿甲醚-本芴醇:一项在非洲无并发症恶性疟原虫疟疾儿童和青少年中开展的随机、双盲 III 期临床试验。
PLoS One. 2009 Aug 19;4(8):e6682. doi: 10.1371/journal.pone.0006682.
9
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.双氢青蒿素-哌喹治疗恶性疟的安全性和有效性:一项前瞻性多中心个体患者数据分析
PLoS One. 2009 Jul 29;4(7):e6358. doi: 10.1371/journal.pone.0006358.
10
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.